Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ADHD
ADHD
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
Fri, 10/7/22 - 10:50 am
ADHD
Adderall
drug shortages
Sandoz
Sun Pharma
Novartis
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Takeda
JNJ
Novartis
ADHD
MHRA
Concerta XL
Ritalin XL
Equasym XL
FDA approves expanded indication for Supernus’ Qelbree for ADHD
Pharmaceutical Business Review
Mon, 05/2/22 - 10:59 am
Supernus Pharmaceuticals
Qelbree
ADHD
FDA
Vallon's abuse-resistant Adderall fails clinical trial, causing stock to crater
Fierce Biotech
Tue, 03/22/22 - 10:11 am
Vallon Pharmaceuticals
ADAIR
Adderall
ADHD
clinical trials
New study shows first FDA-cleared video game treatment for pediatric ADHD improves brain function
MedCity News
Thu, 03/3/22 - 10:12 am
EndeavorRx
ADHD
Medtech
video games
IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork
Endpoints
Fri, 09/10/21 - 11:12 am
IPOs
ADHD
Cingulate
Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million
BioSpace
Thu, 08/12/21 - 12:07 am
Takeda
pay-for-delay
ADHD
generics
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Fierce Pharma
Wed, 04/7/21 - 10:21 am
Supernus Pharmaceuticals
Qelbree
ADHD
drug launches
FDA Approves Novel Non-Stimulant Treatment for ADHD
BioSpace
Mon, 04/5/21 - 02:38 pm
Supernus Pharmaceuticals
ADHD
FDA
pediatric
Qelbree
KemPharm Snags Approval for ADHD Prodrug
BioSpace
Thu, 03/4/21 - 11:25 pm
KemPharm
ADHD
prodrugs
FDA
Azstarys
FDA hits Supernus with double whammy, handing biotech a CRL and RTF on same day
Endpoints
Tue, 11/10/20 - 10:40 am
Supernus
FDA
SPN-812
ADHD
SPN-830
Parkinson's Disease
First video game-based treatment gets go ahead from FDA
RAPS.org
Mon, 06/15/20 - 11:12 pm
digital therapeutics
FDA
video games
Akili Interactive
EndeavorRx
ADHD
COVID-19 gives Akili’s digital ADHD treatment an early debut in US
Pharmaforum
Tue, 04/28/20 - 10:40 am
ADHD
Akili Interactive
digital therapeutics
FDA
COVID-19
Will the FDA give the go-ahead to a prescription video game? The wait goes on, as new data come in
Stat
Tue, 01/21/20 - 11:08 am
ADHD
FDA
video games
Akili Interactive
Supernus Pharmaceuticals seeks FDA approval for ADHD drug
Bizjournals
Tue, 11/12/19 - 07:52 pm
ADHD
FDA
Supernus Pharmaceuticals
SPN-812
Tardy marketing application filing, trial failure troubles Supernus investors
Endpoints
Wed, 11/6/19 - 10:23 am
Supernus
earnings
ADHD
SPN-812
SPN-810
clinical trials
Is the ADHD Market Ready for a Disruptor? An Interview with Highland Therapeutics’ David Lickrish
BioSpace
Fri, 07/12/19 - 12:08 pm
ADHD
Highland Therapeutics
David Lickrish
Jornay PM
FDA Drafts Guidance for Developing Drugs to Treat ADHD
RAPS.org
Fri, 05/3/19 - 10:39 pm
FDA
ADHD
FDA Approves First Pediatric ADHD Device
RAPS.org
Mon, 04/22/19 - 04:38 pm
NeuroSigma
FDA
devices
ADHD
pediatrics
eTNS
Supernus struggles to gain attention
EP Vantage
Fri, 03/29/19 - 10:23 am
Supernus
ADHD
SPN-812
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »